Business news from Greater Lyon
The highlights selected for you
Results: 121-130 out of 139 results
During the 2010 edition of Pollutec exhibition, the CEO of Renault Trucks presented Greater Lyon Authority's President with the keys to a Maxity electric.
Sanofi Pasteur's dengue vaccine is in final stage of clinical development: first phase 3 study underway in Australia.
Erytech Pharma and Genzyme Corporation has signed a collaborative research agreement in rare diseases on 12th October 2010.
Poxel raises EUR 16 million in a series A financing to accelerate pipeline development.
The Lafarge Invention Awards aim to reward and accompany the most inventive projects being developed by researchers and entrepreneurs from across Europe, that can contribute to ever more sustainable...
Vivalis: partnering with Sanofi Pasteur for the discovery of human monoclonal antibodies against infectious diseases
Further to the acquisition of Humalys (a Lyon-based biotechnology company) in January 2010, Vivalis announced the signature with Sanofi Pasteur of a commercial license and collaboration agreement.
The Neurodis foundation publishes its call for projects recruitment 2010.
The Life Sciences sector in Rhone-Alps will be present at the largest meeting in the world in this field, BIO International Convention (Chicago, May 3 to 6 2010).
Imaxio announces a worldwide reciprocal license agreement with Isis Innovation Ltd, to use breakthrough technologies in new vaccine development.
The 12th forum for European animation films will be held in Lyon. Discover Greater Lyon, a region of images!